The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy

Future Medicinal Chemistry

Volumn 6, Issue 7, 2014, Pages 775-792

  Rogers, Luke ^a   Senge, Mathias O ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4' CHLORODIAZEPAM; ADENINE NUCLEOTIDE TRANSLOCASE; BENZODIAZEPINE RECEPTOR; CHOLESTEROL; DIAZEPAM; FLUMAZENIL; HYPERICIN; METHYLENE BLUE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN; PROTEIN; PROTOPORPHYRIN; SINGLET OXYGEN; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; 4 AMINOBUTYRIC ACID RECEPTOR; TSPO PROTEIN, HUMAN;

APOPTOSIS; BINDING AFFINITY; BINDING SITE; CANCER SUSCEPTIBILITY; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SWELLING; CHOLESTEROL TRANSPORT; CONFORMATIONAL TRANSITION; CRYOELECTRON MICROSCOPY; DRUG HALF LIFE; ELECTRON MICROSCOPY; GENE SEQUENCE; HOMEOSTASIS; HUMAN; HYDROPHOBICITY; LIGHT EXPOSURE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTER MEMBRANE; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PORPHYRIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; RHODOBACTER SPHAEROIDES; SCHIZOPHRENIA; STEROIDOGENESIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC USE; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PHOTOCHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALS; HUMANS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA;

EID: 84903130593     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.14.37     Document Type: Review

References (133)

1. Scarf AM, Kassiou M. The translocator protein. J. Nucl. Med. 52, 677-680 (2011
2. Rupprecht R, Papadopoulos V, Rammes G et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971-988 (2010
3. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-Affinity (3H) diazepam binding. Proc. Natl Acad. Sci. USA 74, 3805-3809 (1977
4. Lambert JJ, Belelli D, Hillvenning C, Peters JA. Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16, 295-303 (1995
5. Papadopoulos V, Baraldi M, Guilarte TR et al. Translocator protein (18 kDa): New nomenclature for the peripheral-Type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409 (2006
6. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V. Structural and functional evolution of the translocator protein (18 kDa). Curr. Mol. Med. 12, 369-386 (2012
7. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100, 57-70 (2000
8. Fulda S. Tumor resistance to apoptosis. Int. J. Cancer 124, 511-515 (2009
9. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163 (2007
10. Kroemer G, Pouyssegur J. Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13, 472-482 (2008
11. Galluzzi L, Morselli E, Kepp O et al. Mitochondrial gateways to cancer. Mol. Aspects Med. 31, 1-20 (2010
12. Okaro AC, Fennell DA, Corbo M, Davidson BR, Cotter FE. PK11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-XL and Mcl-1 expressing human cholangiocarcinoma cells. Gut 51, 556-561 (2002
13. Decaudin D, Castedo M, Nemati F et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 62, 1388-1393 (2002
14. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9, 447-464 (2010
15. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS. The voltage-dependent anion channel (VDAC): Function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 12, 2249-2270 (2006
16. Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): Regulation of apoptosis and steroidogenesis as part of the hostdefense response. Curr. Pharm. Des. 13, 2385-2405 (2007
17. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell Endocrinol. 7, 1-12 (2010
18. Chen MK, Guilarte TR. Translocator protein 18kDA (TSPO): Molecular sensor of brain injury and repair. Pharmacol. Ther. 118, 1-17 (2008
19. Papadopoulos V, Amri H, Boujrad N et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids, 62, 21-28 (1997
20. Liu J, Rone MB, Papadopoulos V. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem. 15, 38879-38893 (2006
21. Maaser K, Höpfner M, Jansen A et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell-cycle arrest in human colorectal cancer cells. Br. J. Cancer 85, 1771-1780 (2001
22. Kugler W, Veenman L, Shandalov Y et al. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol. 30, 435-450 (2008
23. Carmel I, Fares FA, Leschiner S, Scherubl H, Weisinger G, Gavish M. Peripheral-Type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem. Pharmacol. 58, 273-278 (1999
24. Batra S, Alenfall J. Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma. Prostate 24, 269-278 (1994
25. Katz Y, Eitan A, Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology 47, 139-142 (1990
26. Katz Y, Ben-Baruch G, Kloog Y, Menczer J, Gavish M. Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. 78, 155-158 (1990
27. Batra S, Iosif CS. Peripheral benzodiazepine receptor in human endometrium and endometrial carcinoma. Anticancer Res. 20, 463-466 (2000
28. Sakai M, Ferraz-de-Paula V, Pinheiro ML et al. Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo. Eur. J. Pharmacol. 626, 131-138 (2010
29. Batarseh A, Barlow KD, Martinez-Arguelles DB, Papadopoulos V. Functional characterization of the human translocator protein (18 kDa) gene promoter in human breast cancer cell lines. Biochim. Biophys. Acta. 38-56 (2012) (1819
30. Parker MA, Bazan HE, Marcheselli V, Rodriguez de Turco EB, Bazan NG. Platelet activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. J. Neurosci. Res. 69, 39-50 (2002
31. De Rosa A, Naviglio D, Di Luccia A. Advances in photodynamic therapy of cancer. Curr. Cancer Ther. Rev. 14, 234-247 (2011
32. Scarf AM, Ittner LM, Kassiou M. The translocator protein (18 kDa): Central nervous system disease and drug design. J. Med. Chem. 52, 581-592 (2009
33. Korkhov VM, Sachse C, Short JM, Tate CG. Threedimensional structure of TSPO by electron cryomicroscopy of helical crystals. Structure 18, 677-687 (2010
34. Luus C, Hanani R, Reynolds A, Kassiou M. The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned?. J. Label. Compd Radiopharm. 53, 501-510 (2010
35. Sprengel R, Werner P, Seeburg PH et al. Molecular cloning and expression of c-DNA encoding a peripheral-Type benzodiazepine receptor. J. Biol. Chem. 264, 20415-20421 (1989
36. Fujimura Y, Ikoma Y, Yasuno F et al. Quantitative analyses of 18F-FEDAA1106 Binding to peripheral benzodiazepine receptors in living human brain. J. Nucl. Med. 47, 43-50 (2006
37. Zhang M, Maeda J, Ogawa M et al. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F] fluoroethyl-5-methoxybenzyl)acetamide, for PET Imaging of peripheral benzodiazepine receptor in primate brain J. Med. Chem. 47, 2228-2235 (2004
38. Okuyama S, Chaki S, Yoshikawa R et al. Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106. Life Sci. 64, 1455-1464 (1999
39. Vas A, Shchukin Y, Karrenbauer VD et al. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C] vinpocetine and [11C]PK11195 in patients. J. Neurol. Sci. 264, 9-17 (2008
40. Kita A, Kohayakawa H, Kinoshita T et al. Anti-Anxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br. J. Pharmacol. 142, 1059-1072 (2004
41. Amitani M, Zhang MR, Noguchi J et al. Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma. Nucl. Med. Biol. 33, 971-975 (2006
42. Margiotta N, Denora N, Ostuni R et al. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein J. Med. Chem. 53(14), 5144-5154 (2010
43. Piccinonna S, Margiotta N, Denora N et al. A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO). Dalton Trans. 42(28), 10112-10115 (2013
44. Denora N, Laquintana V, Pisu MG et al. 2-phenylimidazo[ 1,2-A]pyridine compounds containing hydrophilic groups as potent and selective ligands for peripheral benzodiazepine receptors: Synthesis, binding affinity and electrophysiological studies. J. Med. Chem. 51(21), 6876-6888 (2008
45. Sekimata K, Hatano K, Ogawa M et al. Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. Nucl. Med. Biol. 35, 327-334 (2008
46. Margiotta N, Ostuni R, Ranaldo R et al. Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor. Med. Chem. 50, 1019-1027 (2007
47. Verma A, Nye JS, Snyder SH. Porphyrins are endogenous ligands for the mitochondrial (peripheral-Type) benzodiazepine receptor. Proc. Natl Acad. Sci. USA 84, 2256-2260 (1987
48. Pavese N, Gerhard A, Tai YF et al. Microglial activation correlates with severity in Huntington disease: A clinical and PET study. Neurology 66, 1638-1643 (2006
49. Farges R, Joseph-Liauzun E, Shire D, Caput D, Le Fur G, Ferrara P. Site-directed mutagenesis of the peripheral benzodiazepine receptor: Identification of amino acids implicated in the binding site of Ro5-4864. Mol. Pharmacol. 46, 1160-1167 (1994
50. Lin D, Chang YJ, Strauss JF, Miller WL. The human peripheral benzodiazepine receptor gene: Cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 18, 643-650 (1993
51. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18 kDa) in microglia: From pathology to imaging. Prog. Neurobiol. 80, 308-322 (2006
52. Camsonne R, Crouzel C, Comar D et al. Synthesis of N-(11C) methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoline carboxamide-3 (PK 11195): A new ligand for peripheral benzodiazepine receptors. J. Label. Compd. Radiopharm. 21, 985-991 (1984
53. Bergström M, Mosskin M, Ericson K et al. Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography. Acta Radiol. Suppl. 369, 409-411 (1986
54. Deane NG, Manning HC, Foutch AC et al. Targeted imaging of colonic tumors in smad3-/-mice discriminates cancer and inflammation. Mol. Cancer Res. 5, 341-349 (2007
55. Wyatt SK, Manning HC, Bai M et al. Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer. Mol. Imaging Biol. 12, 349-358 (2010
56. Tang D, Hight MR, McKinley ET et al. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F fluoroethoxy)phenyl)- 5,7-dimethylpyrazolo[1,5-A]pyrimidin-3-yl)-Acetamide. J. Nucl. Med. 53, 287-294 (2012
57. Buck JR, McKinley ET, Hight MR et al. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5- dimethoxybenzyl)-2-phenoxyaniline. J. Nucl. Med. 52, 107-114 (2011
58. James ML, Fulton RR, Vercoullie J et al. DPA-714, a new translocator protein-specific ligand: Synthesis, radiofluorination, and pharmacologic characterization. J. Nucl. Med. 49, 814-822 (2008
59. Tang D, McKinley ET, Hight MR et al. Synthesis and structure-Activity relationships of 5,6,7-substituted pyrazolopyrimidines: Discovery of a novel TSPO PET ligand for cancer imaging. J. Med. Chem. 56, 3429-3433 (2013
60. Ethirajan M, Chen Y, Joshi P, Pandey RK. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem. Soc. Rev. 40, 340-362 (2011
61. Kessel D, Dougherty TJ. Agents used in photodynamic therapy. Rev. Contemp. Pharmacother. 10, 19-24 (1999
62. Locos OB, Heindl AC, Corral A, Senge MO, Scanlan EM. Efficient synthesis of glycoporphyrins by microwave-mediated'click' reactions. Eur. J. Org. Chem. 1026-1028 (2010
63. Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome-or LDL-Administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br. J. Cancer 61, 407-411 (1990
64. Hudson R, Boyle RW. Strategies for selective delivery of photodynamic sensitisers to biological targets. J. Porphyr. Phthalocyanines 8, 954-975 (2004
65. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. Ther. 8, 14-29 (2011
66. Verma A, Facchina SL, Hirsch DJ et al. Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target. Mol. Med. 4, 40-55 (1998
67. Taketani S, Kohno H, Furukawa T, Tokunaga R. Involvement of peripheral-Type benzodiazepine receptors in the intracellular transport of heme and porphyrins. J. Biochem. 117, 875-880 (1995
68. Berns MW, Dahlman A, Johnson FM et al. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 42, 2325-2329 (1982
69. Roberts WG, Berns MW. In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-Aspartyl chlorin e6, chloro-Aluminum sulfonated phthalocyanine, and photofrin II. Lasers Surg. Med. 9, 90-101 (1989
70. Perlin DS, Murant RS, Gibson SL, Hilf R. Effects of photosensitization by hematoporphyrin derivative on mitochondrial adenosine triphosphatase-mediated proton transport and membrane integrity of R3230AC mammary adenocarcinoma. Cancer Res. 45, 653-658 (1985
71. Salet C. Hematoporphyrin and hematoporphyrin-derivative photosensitization of mitochondria. Biochimie 68, 865-868 (1986
72. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905 (1998
73. Agostinis P, Vantieghem A, Merlevede W, de Witte PA. Hypericin in cancer treatment: More light on the way. Int. J. Biochem. Cell Biol. 34, 221-241 (2002
74. Nyman ES, Hynninen PH. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B:Biol. 73, 1-28 (2004
75. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acidbased photodynamic therapy: Clinical research and future challenges. Cancer 79, 2282-2308 (1997
76. Senge MO, Brandt JC. Temoporfin (Foscan®, 5,10,15,20-Tetra(m- hydroxyphenyl)chlorin)-A secondgeneration photosensitizer. Photochem. Photobiol. 87, 1240-1296 (2011
77. Sternberg ED, Dolphin D, Brückner C. Porphyrinbased photosensitizers for use in photodynamic therapy. Tetrahedron 54, 4151-4202 (1998
78. Rosenberg N, Rosenberg O, Weizman A, Veenman L, Gavish M. In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: Possible role of the 18 kDa mitochondrial translocator protein. J. Bioenerg. Biomembr. 45, 333-341 (2013
79. Mantione CR, Weissman BA, Goldman ME, Paul SM, Skolnick P. Endogenous inhibitors of 4'-[3H] chlorodiazepam (Ro 5-4864) binding to 'peripheral' sites for benzodiazepines. FEBS Lett. 176, 69-74 (1984
80. Schoemaker H, Boles RG, Horst WD, Yamamura HI. Specific high-Affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J. Pharamcol. Exp. Ther. 225, 61-69 (1983
81. Ortel B, Chen N, Brissette J, Dotto GP, Maytin E, Hasan T. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br. J. Cancer 77, 1744-1751 (1998
82. Furre IE, Shahzidi S, Luksiene Z et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 65, 11051-11060 (2005
83. Dailey HA. Terminal steps of haem biosynthesis. Biochem. Soc. Trans. 30, 590-595 (2002
84. Kinnally K, Zorov DB, Antonenko YN, Snyder SH, McEnery MW, Tedeschi H. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl Acad. Sci. USA 90, 1374-1378 (1993
85. Kessel D, Antolovich M, Smith KM. The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. Photochem. Photobiol. 74, 346-349 (2001
86. Ben-Dror S, Bronshtein I, Wiehe A, Röder B, Senge MO, Ehrenberg B. On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers. Photochem. Photobiol. 82, 695-701 (2006
87. Mojzisova H, Bonneau S, Brault D. Structural and physicochemical determinants of the interactions of macrocyclic photosensitizers with Cells. Eur. Biophys. J. 36, 943-953 (2007
88. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid production in variant, glycolysis-deficient and parental tumors in vivo: Support for hypothesized tumor metabolism. Clin. Cancer Res. 8, 1284-1291 (2002
89. Bombalska A, Graczyk A. Interactions of protoporphyrin IX and its derivatives with benzodiazepine receptor. Photodiagn. Photodyn. Ther. 6, 46-51 (2009
90. Senge MO, Forsyth TP, Nguyen LT, Smith KM. Sterically strained porphyrins-influence of core protonation and peripheral substitution on the conformation of tetra-meso-, Octa-ß-, and dodeca-substituted porphyrin dications. Angew. Chem. Int. Ed. Engl. 33, 2485-2487 (1995
91. Senge MO. Exercises in molecular gymnastics-bending, stretching and twisting porphyrins. Chem. Commun. 243-256 (2006
92. Sinclair RS, Tait D, Truscott TG. Triplet states of protoporphyrin IX and protoporphyrin IX dimethyl ester. J. Chem. Soc. Faraday Trans. 76, 417-425 (1980
93. Senge MO, Medforth CJ, Forsyth TP et al. Comparative analysis of the conformations of symmetrically and asymmetrically deca-And undecasubstituted porphyrins bearing meso-Alkyl or-Aryl groups. Inorg. Chem. 36, 1149-1163 (1997
94. Bombalska A, Graczyk A. Interactions of the Peripheraltype benzodiazepine receptor with diamino acid derivatives of protoporphyrin IX. J. Photochem. Photobiol. B. Biol. 94, 138-142 (2009
95. Chen Y, Potter WR, Missert JR, Morgan J, Pandey RK. Comparative in vitro and in vivo studies on long-wavelength photosensitizers derived from bacteriopurpurinimide and bacteriochlorin p6: Fused imide ring enhances the in vivo PDT efficacy. Bioconjug. Chem. 18, 1460-1473 (2007
96. Pandey SK, Gryshuk AL, Sajjad M et al. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible 'see and treat' approach. J. Med. Chem. 48, 6286-6295 (2005
97. Chen Y, Graham A, Potter W et al. Bacteriopurpurinimides: Highly stable and potent photosensitizers for photodynamic therapy. J. Med. Chem. 45, 255-258 (2002
98. Morris RL, Varnes ME, Kenney ME et al. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Photochem. Photobiol. 75, 652-661 (2002
99. Massoud TF, Gambhir SS. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003
100. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat. Rev. Drug Discov. 2, 123-131 (2003
101. Verel I, Vissser GW, van Dongen GA. The promise of immuno-PET in radioimmunotherapy. J. Nucl. Med. 46, 164-171 (2005
102. Koziorowski J, Henssen C, Weinreich R. A new convenient route to radioiodinated N-succinimidyl 3-And 4-iodobenzoate, two reagents for radioiodination of proteins. Appl. Radiat. Isot. 49, 955-959 (1998
103. Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. High-quality 124I-labeled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imaging 31, 1645-1652 (2004
104. Chen Y, Sajjad M, Wang Y, Batt C, Nabi HA, Pandey RK. TSPO 18 kDa (PBR) targeted photosensitizers for cancer imaging (PET) and PDT. Med. Chem. Lett. 2, 136-141 (2011
105. Chen Y, Zheng X, Dobhal MP et al. Methyl pyropheophorbide-A analogues: Potential fluorescent probes for the peripheral-Type benzodiazepine receptor. effect of central metal in photosensitizing efficacy. J. Med. Chem. 48, 3692-3695 (2005
106. Chen YH, Li GL, Pandey RK. Synthesis of bacteriochlorins and their potential utility in photodynamic therapy (PDT). Curr. Org. Chem. 8 1105-1134 (2004
107. Li G, Graham A, Chen Y et al. Synthesis, comparative photosensitizing efficacy, human serum albumin (Site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vicdihydroxybacteriochlorins. J. Med. Chem. 46, 5349-5359 (2003
108. Graham A, Li G, Chen Y et al. Structure-Activity relationship of new octaethylporphyrin-based benzochlorins as photosensitizers for photodynamic therapy. Photochem. Photobiol. 77, 561-566 (2003
109. Wendler G, Lindemann P, Lacapere JJ, Papdopoulos V. Protoporphyrin IX binding and transport by recombinant mouse PBR. Biochem. Biophys. Res. Commun. 311, 847-852 (2003
110. Kessel D. Interactions between porphyrins and mitochondrial benzodiazepine receptors. Cancer Lett. 39, 193-198 (1988
111. Verma A, Snyder SH. Characterization of porphyrin interactions with peripheral type benzodiazepine receptors. Mol. Pharmacol. 34, 800-805 (1988
112. Hirsch JD, Beyer CF, Malkowitz L, Loullis CC, Blume AJ. Characterization of ligand binding to mitochondrial benzodiazepine receptors. Mol. Pharmacol. 35, 164-172 (1989
113. Verma A, Facchina SL, Hirsch DJ et al. Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target. Mol. Med. 4, 40-45 (1998
114. Joseph-Liazun E, Farges R, Delmas P, Ferrara P, Loison G. The Mr 18,000 subunit of the peripheral-Type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltagedependent anion channel or the adenine nucleotide carrier. J. Biol. Chem. 272, 28102-28106 (1997
115. Li H, Papadopoulos V. Peripheral-Type benzodiazepine receptor function in cholesterol transport. identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997 (1998
116. Yeliseev AA, Kaplan S. A sensory transducer homologous to the mammalian peripheral-Type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J. Biol. Chem. 270, 21167-21175 (1995
117. Yeliseev AA, Kaplan S. TspO of Rhodobacter sphaeroides: A structural and functional model for the mammalian peripheral benzodiazepine receptor. J. Biol. Chem. 275, 5657-5667 (2000
118. Goldman BS, Beck DL, Monika EM, Kranz RG. Transmembrane heme delivery systems. Proc. Natl Acad. Sci. USA 95, 5003-5008 (1998
119. Joseph-Liauzun E, Delmas P, Shire D, Ferrara P. Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-Transmembrane structure. J. Biol.Chem. 273, 2146-2152 (1998
120. Yeliseev AA, Krueger KE, Kaplan S. A mammalian mitochondrial drug receptor functions as a bacterial 'oxygen' sensor. Proc. Natl. Acad. Sci. USA 94, 5101-5106 (1997
121. Li F, Xia Y, Meiler J, Ferguson-Miller S. Characterization and Modeling of the oligomeric state and ligand binding behavior of purified translocator protein 18kDa from Rhodobacter sphaeroides. Biochemistry 52, 5884-5899 (2013
122. Baker ME, Fanestil DD. Mammalian peripheral-Type benzodiazepine receptor is homologous to CrtK protein of Rhodobacter capsulatus, a photosynthetic bacterium. Cell 65, 721-722 (1991
123. Yeliseev AA, Kaplan S. A novel mechanism for the regulation of photosynthesis gene expression by the TSPO outer membrane protein of Rhodobacter sphaeroides 2.4.1. J. Biol. Chem. 274, 21234-21243 (1999
124. Guillaumot D, Guillon S, Déplanque T et al. The Arabidopsis TSPO-related protein is a stress and abscisic acidregulated, endoplasmic reticulum-Golgi-localized membrane protein. Plant J. 60, 242-256 (2009
125. Lindemann P, Koch A, Degenhardt B, Hause G, Grimm B, Papadopoulos V. A novel Arabidopsis thaliana protein is a functional peripheral-Type benzodiazepine receptor. Plant Cell Physiol. 45, 723-733 (2004
126. Frank W, Baar KM, Qudeimat E et al. A mitochondrial protein homologous to the mammalian peripheral-Type benzodiazepine receptor is essential for stress adaptation in plants. Plant J. 51, 1004-1018 (2007
127. Avallone R, Cosenza F, Farina F, Baraldi C, Baraldi M. Extraction and purification from Ceratonia siliqua of compounds acting on central and peripheral benzodiazepine receptors. Fitoterapia 73, 390-396 (2002
128. Kurumaji A, Wakai T, Toru M. Decreases in peripheral type benzodiazepine receptors in postmortem brain of chronic schizophrenics. J. Neural Transm. 104, 1361-1370 (1997
129. Ritsner M, Modai I, Gibel A et al. Decreased platelet peripheral-Type benzodiazepine receptors inpersistently violent schizophrenia patients. J. Psychiatr. Res. 37, 549-556 (2003
130. Becker DM, Kramer S. The neurological manifestations of porphyria: A review. Medicine 56, 411-423 (1977
131. Scarf AM, Auman KM, Kassiou M. Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)?. Curr. Mol. Med. 12, 387-397 (2012
132. Scarf AM, Luus C, Da Pozzo E et al. Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa). Curr. Mol. Med. 12, 488-493 (2012
133. Gonzalez-Polo RA, Carvalho G, Braun T et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepine receptor. Oncogene 24, 7503-7513 (2005.